95 results
Page 5 of 5
6-K
EX-99.1
3usu4hvhws69baj
31 Jul 19
Therapix Biosciences Announces Canadian Product License Issuance for TheraPEA (CannAmide™), a Non-Opiate Based Pain Management Supplement
4:03pm
6-K
EX-99.1
yassg1g9hfykvaey
5 Jul 19
Therapix Biosciences Announces First Quarter 2019 Condensed Financial Data
6:08am
6-K
EX-99.1
kbx84
18 Jun 19
Therapix Biosciences Announces Interim Results of Phase IIa Study at Assuta Medical Center for Obstructive Sleep Apnea Program
4:09pm
424B5
02z0d6tp28zei fucfxe
1 Apr 19
Prospectus supplement for primary offering
6:57am
6-K
EX-10.1
x0abfen7r4100cqdsn3
28 Mar 19
Therapix Biosciences Announces Pricing
8:51am
6-K
EX-99.1
hogpz0a c6d
6 Dec 18
Therapix Biosciences Reports Third
6:18am
6-K
EX-99.1
newouvhg
28 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:27am
424B2
84pci2xa
9 Aug 18
Prospectus for primary offering
11:19am
F-3/A
mnw6d0wl8vx7qhn
17 Jul 18
Shelf registration (foreign) (amended)
1:29pm
F-3
a8i9r0440cfhvjnuueu2
20 Jun 18
Shelf registration (foreign)
2:38pm
6-K
EX-99.1
1656dp7
6 Jun 18
Therapix Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update
4:55pm
20-F
EX-4.3
8f2oc
1 May 17
Annual report (foreign)
12:00am
20-F
p7i2xux9iu5b gfur
1 May 17
Annual report (foreign)
12:00am